Metformin is a medication prescribed to help manage type 2 diabetes. Recent research suggests, however, this medication may potentially decrease risk of certain types of skin cancer.

researchers compared the risk of hematologic cancers in type 2 diabetes (T2D) patients treated with glucagon-like peptide 1 receptor agonists (GLP-1RAs). Obesity and T2D have been recognized as ...

These metabolic benefits may have led to its promotion as an alternative or adjunct to metformin, despite its lack of FDA approval for diabetes treatment," accompanying commentary author Nestoras ...

For a long time, we have been told that watching too much TV is not good for our health, and a new study has revealed the ...

The findings of the study have been published in Nature Medicine and will be presented at the Diabetes UK Professional Conference 2025 in Glasgow. Dr Elizabeth Robertson, director of research and ...

although it can increase a woman’s risk of developing type 2 diabetes later in life. With this new understanding, we have the opportunity to help more mothers experience a healthy pregnancy ...

The findings of the study have been published in Nature Medicine and will be presented at the Diabetes UK Professional Conference 2025 in Glasgow. Dr Elizabeth Robertson, director of research and ...